Evolocumab to reduce first major cardiovascular events in patients without known significant atherosclerosis and with diabetes: results from the VESALIUS-CV trial
Marston NA, Bohula EA, Bhatia AK, et al.
JAMA. Pub. online 28 Mar 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Cardiorenal outcomes with tirzepatide compared with dulaglutide in patients with diabetes and cardiovascular disease: a post hoc analysis of the SURPASS-CVOT randomized clinical trial
Nissen SE, Wolski K, D’Alessio D, et al.
JAMA Cardiol. Pub. online 28 Mar 2026.
Leggi
Metabolic and bariatric surgery for patients with obesity type 1 diabetes mellitus: a comprehensive updated systematic review and meta-analysis
Mitchell S, Patwardhan K, Lucocq J, et al.
Diabet Med. Pub. online 28 Mar 2026.
Leggi
Lower risk of cardiovascular events in patients with clinical atherosclerotic cardiovascular disease who initiated semaglutide 2.4 mg in the real-world: results from the SCORE—clinical ASCVD study
Nanna MG, Mena-Hurtado C, Divino V, et al.
Diabetes Obes Metab. Pub. online 26 Mar 2026.
Leggi
Lean mass changes with incretin therapy versus lifestyle intervention: a systematic review and meta‐analysis of randomised controlled trials
Eisa N, Barood O
Diabetes Obes Metab. Pub. online 24 Mar 2026.
Leggi
Waist-to-height ratio and the risk of cardiovascular outcomes and mortality in type 2 diabetes with and without abdominal obesity
Park KY, Han K, Park JH, et al.
Diabetes Obes Metab. Pub. online 24 Mar 2026.
Leggi
Oral semaglutide and change in cardiovascular risk factors in high-risk type 2 diabetes: a post hoc secondary analysis of the SOUL randomized clinical trial
Mulvagh SL, Inzucchi SE, Marx N, et al.
JAMA Cardiol. Pub. Online 25 Mar 2026.
Leggi
Quality-score (Q-Score) can be more sensitive than %time in range and several other CGM metrics in detecting responses to therapeutic interventions
Rodbard D, Augstein P, Heinke P, et al.
Diabetes Technol Ther. Pub. Online 27 Mar 2026.
Leggi
Per- and polyfluoroalkyl substances during pregnancy and gestational diabetes: the environmental influences on child health outcomes (ECHO) cohort
Starling AP, Burjak M, Nzegwu AW, et al.
Diabetes Care. Pub. Online 24 Mar 2026.
Leggi
Profiles of social determinants of health and change in diabetes status among U.S. hispanic/latino adults: HCHS/SOL, 2008–2024
Brown CJ, Roesch SC, Rosas CE, et al.
Diabetes Care. Pub. Online 24 Mar 2026.
Leggi